These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1071 related articles for article (PubMed ID: 17388990)

  • 21. High prevalence of LRRK2 mutations in familial and sporadic Parkinson's disease in Portugal.
    Ferreira JJ; Guedes LC; Rosa MM; Coelho M; van Doeselaar M; Schweiger D; Di Fonzo A; Oostra BA; Sampaio C; Bonifati V
    Mov Disord; 2007 Jun; 22(8):1194-201. PubMed ID: 17469194
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of novel variants in LRRK2 gene in patients with Parkinson's disease in Serbian population.
    Janković MZ; Kresojević ND; Dobričić VS; Marković VV; Petrović IN; Novaković IV; Kostić VS
    J Neurol Sci; 2015; 353(1-2):59-62. PubMed ID: 25899316
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRRK2 G2019S is a common mutation in Spanish patients with late-onset Parkinson's disease.
    Infante J; Rodríguez E; Combarros O; Mateo I; Fontalba A; Pascual J; Oterino A; Polo JM; Leno C; Berciano J
    Neurosci Lett; 2006 Mar; 395(3):224-6. PubMed ID: 16298482
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frequency of the LRRK2 G2019S mutation in siblings with Parkinson's disease.
    Lesage S; Leclere L; Lohmann E; Borg M; Ruberg M; Dürr A; Brice A;
    Neurodegener Dis; 2007; 4(2-3):195-8. PubMed ID: 17596714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Frequency and phenotypes of LRRK2 G2019S mutation in Italian patients with Parkinson's disease.
    Marongiu R; Ghezzi D; Ialongo T; Soleti F; Elia A; Cavone S; Albanese A; Altavista MC; Barone P; Brusa L; Cortelli P; Petrozzi L; Scaglione C; Stanzione P; Tinazzi M; Zeviani M; Dallapiccola B; Bentivoglio AR; Valente EM; Garavaglia B;
    Mov Disord; 2006 Aug; 21(8):1232-5. PubMed ID: 16622859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical molecular genetics for PARK8 (LRRK2)].
    Tomiyama H; Hatano T; Hattori N
    Brain Nerve; 2007 Aug; 59(8):839-50. PubMed ID: 17713120
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fall risk and gait in Parkinson's disease: the role of the LRRK2 G2019S mutation.
    Mirelman A; Heman T; Yasinovsky K; Thaler A; Gurevich T; Marder K; Bressman S; Bar-Shira A; Orr-Urtreger A; Giladi N; Hausdorff JM;
    Mov Disord; 2013 Oct; 28(12):1683-90. PubMed ID: 24123150
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Motor phenotype of LRRK2-associated Parkinson's disease: a Tunisian longitudinal study.
    Nabli F; Ben Sassi S; Amouri R; Duda JE; Farrer MJ; Hentati F
    Mov Disord; 2015 Feb; 30(2):253-8. PubMed ID: 25487881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
    Ishihara L; Warren L; Gibson R; Amouri R; Lesage S; Dürr A; Tazir M; Wszolek ZK; Uitti RJ; Nichols WC; Griffith A; Hattori N; Leppert D; Watts R; Zabetian CP; Foroud TM; Farrer MJ; Brice A; Middleton L; Hentati F
    Arch Neurol; 2006 Sep; 63(9):1250-4. PubMed ID: 16966502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The LRRK2 I2012T, G2019S and I2020T mutations are not common in patients with essential tremor.
    Deng H; Le W; Davidson AL; Xie W; Jankovic J
    Neurosci Lett; 2006 Oct; 407(2):97-100. PubMed ID: 16939701
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The G6055A (G2019S) mutation in LRRK2 is frequent in both early and late onset Parkinson's disease and originates from a common ancestor.
    Goldwurm S; Di Fonzo A; Simons EJ; Rohé CF; Zini M; Canesi M; Tesei S; Zecchinelli A; Antonini A; Mariani C; Meucci N; Sacilotto G; Sironi F; Salani G; Ferreira J; Chien HF; Fabrizio E; Vanacore N; Dalla Libera A; Stocchi F; Diroma C; Lamberti P; Sampaio C; Meco G; Barbosa E; Bertoli-Avella AM; Breedveld GJ; Oostra BA; Pezzoli G; Bonifati V
    J Med Genet; 2005 Nov; 42(11):e65. PubMed ID: 16272257
    [TBL] [Abstract][Full Text] [Related]  

  • 32. LRRK2 G2019S mutation does not contribute to Parkinson's disease in South India.
    Vijayan B; Gopala S; Kishore A
    Neurol India; 2011; 59(2):157-60. PubMed ID: 21483109
    [TBL] [Abstract][Full Text] [Related]  

  • 33. G2019S mutation of the leucine-rich repeat kinase 2 gene in a cohort of Egyptian patients with Parkinson's disease.
    Hashad DI; Abou-Zeid AA; Achmawy GA; Allah HM; Saad MA
    Genet Test Mol Biomarkers; 2011 Dec; 15(12):861-6. PubMed ID: 21699405
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries.
    Tomiyama H; Li Y; Funayama M; Hasegawa K; Yoshino H; Kubo S; Sato K; Hattori T; Lu CS; Inzelberg R; Djaldetti R; Melamed E; Amouri R; Gouider-Khouja N; Hentati F; Hatano Y; Wang M; Imamichi Y; Mizoguchi K; Miyajima H; Obata F; Toda T; Farrer MJ; Mizuno Y; Hattori N
    Mov Disord; 2006 Aug; 21(8):1102-8. PubMed ID: 16622854
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adenoviral-mediated expression of G2019S LRRK2 induces striatal pathology in a kinase-dependent manner in a rat model of Parkinson's disease.
    Tsika E; Nguyen AP; Dusonchet J; Colin P; Schneider BL; Moore DJ
    Neurobiol Dis; 2015 May; 77():49-61. PubMed ID: 25731749
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical features of LRRK2-associated Parkinson's disease in central Norway.
    Aasly JO; Toft M; Fernandez-Mata I; Kachergus J; Hulihan M; White LR; Farrer M
    Ann Neurol; 2005 May; 57(5):762-5. PubMed ID: 15852371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The LRRK2 R1441C mutation is more frequent than G2019S in Parkinson's disease patients from southern Italy.
    Criscuolo C; De Rosa A; Guacci A; Simons EJ; Breedveld GJ; Peluso S; Volpe G; Filla A; Oostra BA; Bonifati V; De Michele G
    Mov Disord; 2011 Aug; 26(9):1733-6. PubMed ID: 21538529
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of the LRRK2 p.G2019S mutation in Colombian Parkinson's Disease Patients.
    Duque AF; Lopez JC; Benitez B; Hernandez H; Yunis JJ; Fernandez W; Arboleda H; Arboleda G
    Colomb Med (Cali); 2015 Sep; 46(3):117-21. PubMed ID: 26600626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of the LRRK2 G2019S mutation in Italian patients affected by Parkinson's disease.
    Squillaro T; Cambi F; Ciacci G; Rossi S; Ulivelli M; Malandrini A; Mencarelli MA; Mari F; Renieri A; Ariani F
    J Hum Genet; 2007; 52(3):201-204. PubMed ID: 17235449
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The G2019S LRRK2 mutation is rare in Korean patients with Parkinson's disease.
    Cho JW; Kim SY; Park SS; Kim HJ; Ahn TB; Kim JM; Jeon BS
    Can J Neurol Sci; 2007 Feb; 34(1):53-5. PubMed ID: 17352347
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 54.